Latest Breaking News On - Thomas voit - Page 1 : vimarsana.com

Rapid Genome Sequencing Boosts Epilepsy Treatment in Kids

Antisense Therapeutics (ASX:ANP) receives first approval for phase two DMD clinical trial

Antisense Therapeutics (ASX:ANP) has received approval to conduct its phase two trial in non-ambulant boys with DMD in Turkey.

Researchers combine motion capture and AI to treat movement disorders

UK researchers have shown that AI can be combined with motion capture suits to create a "faster, cheaper" way of treating movement disorders.

Using motion capture technology and AI to monitor the progression of movement disorders

A multi-disciplinary team of researchers has developed a way to monitor the progression of movement disorders using motion capture technology and AI.

Teams Unite to Revolutionize Clinical Trial Monitoring with Wearables, AI

Wearable Tech and AI Combine to Track Progression of Movement Disorders

Combining new wearable technology and artificial intelligence, researchers are better able to track motion and monitor the progression of movement disorders.

World-class health research at UCL awarded £145M

UCL is the research partner of the NIHR UCLH BRC, awarded £90m, the NIHR Great Ormond Street Hospital (GOSH) BRC, awarded £35m, and the NIHR Moorfields BRC, awarded £20m. The total award to UCL is the most of any UK university and signals the strength of UCL’s world-class translational research and scientific discovery.

World-class health research at UCL awarded £145m